ALCRESTA
Alcresta is developing and commercializing innovative, point-of-care, enzyme-based nutritional products that support improved nutrition and manage disease for infants, aging adults and people battling acute conditions or chronic diseases. Alcresta’s research-based approach is innovative, proprietary and driven by the unmet nutritional needs of those people with compromised health. Alcresta’s core capabilities include expertise in adult and pediatric nutrition, as well as protein manufacturing expertise and regulatory experience that support the development and commercialization of its programs. The company’s platform is supported by the Alcresta team’s proven success in developing protein therapeutics.
ALCRESTA
Social Links:
Industry:
Biotechnology Health Care Medical Device
Founded:
2011-01-01
Address:
Newton, Massachusetts, United States
Country:
United States
Website Url:
http://www.alcresta.com
Total Employee:
11+
Status:
Active
Contact:
617-916-1207
Email Addresses:
[email protected]
Total Funding:
139.39 M USD
Technology used in webpage:
ReCAPTCHA CrUX Dataset CrUX Top 50m ReCAPTCHA V3 Verizon Verizon FIOS
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Sesen Bio, Inc.
Sesen Bio, Inc. is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Mercator MedSystems
Mercator MedSystems develops site-specific delivery devices for the treatment of vascular, oncologic, and regenerative diseases.
Myomo
Myomo develops devices with myoelectric prosthetic technology to restore the mobility of individuals with muscle weakness.
Nano Precision Medical
Nano Precision Medical develops novel miniaturized subdermal implants
Tandem Diabetes Care
Tandem diabetes care provides products that empower both people with diabetes and those who care for them.
Current Advisors List
Current Employees Featured
Founder
Investors List
HealthQuest Capital
HealthQuest Capital investment in Series C - Alcresta
Bessemer Venture Partners
Bessemer Venture Partners investment in Series C - Alcresta
Bessemer Venture Partners
Bessemer Venture Partners investment in Series B - Alcresta
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series B - Alcresta
Third Rock Ventures
Third Rock Ventures investment in Series B - Alcresta
Third Rock Ventures
Third Rock Ventures investment in Series A - Alcresta
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - Alcresta
Bessemer Venture Partners
Bessemer Venture Partners investment in Series A - Alcresta
Key Employee Changes
Official Site Inspections
http://www.alcresta.com Semrush global rank: 5.84 M Semrush visits lastest month: 1.23 K
- Host name: 172.67.191.143
- IP address: 172.67.191.143
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Alcresta"
Alcresta - Crunchbase Company Profile & Funding
Alcresta’s research-based approach is innovative, proprietary and driven by the unmet nutritional needs of those people with compromised health. Alcresta’s core capabilities include expertise …See details»
Alcresta Therapeutics
Alcresta develops rare disease, enzyme-based products helping to address fat malabsorption (often due to exocrine pancreatic insufficiency) in patients who are enterally fed at home or in the hospital. Our RELiZORB ® cartridge contains …See details»
Alcresta Therapeutics - LinkedIn
Alcresta Therapeutics is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare ...See details»
Alcresta Therapeutics Company Profile 2024: Valuation, …
Alcresta Therapeutics General Information Description. Developer of enzyme-based products designed to combat gastrointestinal disorders. The company's digestive enzyme cartridge has been designed to mimic the function of …See details»
Alcresta Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Alcresta Therapeutics, Inc. of Waltham, MA. Get the latest business insights from Dun & Bradstreet.See details»
Alcresta Company Profile - Office Locations, Competitors ... - Craft
Alcresta is a company developing and commercializing innovative enzyme-based nutritional products that support improved nutrition and manage the disease for infants, aging adults and …See details»
Linden Capital Partners Acquires Alcresta Therapeutics, Inc.
Chicago, IL and Waltham, MA (March 12, 2024) – Linden Capital Partners ("Linden"), a Chicago-based private equity firm focused exclusively on the healthcare industry, announced today the …See details»
Alcresta - Funding, Financials, Valuation & Investors - Crunchbase
Alcresta is funded by 4 investors. HealthQuest Capital and Bessemer Venture Partners are the most recent investors. Alcresta has a post-money valuation in the range of $100M to $500M …See details»
Linden Invests in Alcresta Therapeutics
Mar 12, 2024 We have been impressed with the organization and team that Daniel has built and are excited to partner with Alcresta on this next phase of growth.” Linden’s Ernest Waaser and …See details»
Alcresta - Contacts, Employees, Board Members, Advisors & Alumni
Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. …See details»
Linden Capital Partners Acquires Alcresta Therapeutics, Inc.
Mar 12, 2024 Linden Capital Partners ("Linden"), a Chicago-based private equity firm focused exclusively on the healthcare industry, announced today the completion of its acquisition of …See details»
Alcresta Therapeutics Investors
Aug 31, 2023 Alcresta Therapeutics Announces Publication of Cystic Fibrosis Foundation Position Paper Confirming Inline Enzyme Cartridges are Safe and Effective. Mar 16, 2023. …See details»
Alcresta Therapeutics Announces FDA Clearance for the Next …
Dec 21, 2023 Alcresta Therapeutics, Inc. is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by patients living with …See details»
Working at Alcresta Therapeutics - Zippia
Mar 14, 2024 Zippia gives an in-depth look into the details of Alcresta Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about …See details»
Alcresta Therapeutics Announces Move to New Corporate …
Dec 5, 2022 Alcresta Therapeutics, Inc. is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by patients living with …See details»
Alcresta Therapeutics Announces Move to New Corporate …
Waltham, MA—December 5, 2022—Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today …See details»
Alcresta Therapeutics Announces Commercial Availability of Next ...
May 13, 2024 Alcresta Therapeutics, Inc. is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by patients living with …See details»
Science | Alcresta Therapeutics
Alcresta’s proprietary enzyme immobilization technology contains iLipase, the digestive enzyme lipase attached to polymeric microbead carriers, and is stored within a device that easily …See details»
Alcresta Therapeutics Announces Publication of NASPGHAN …
Newton, M.A. – February, 23 2021 – Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today …See details»